Endocrine Abstracts

Background: The prevalence of pituitary adenomas (PAs) is increasing as the development of imaging techniques. The objective of this study is to assess the clinical and morphological features of non-functioning, prolactin, and grown-hormone secreting pituitary adenomas and to analyze the accompanying diseases of each condition.Methods: A retrospective analysis of the clinical records of patients with non-functioning (NFPA), prolactin (PRL+) or grown horm...

Background: Dopamine agonists (DAs) are the primary treatment for both microprolactinomas and macroprolactinomas. Two medications are FDA approved for the medical treatment of prolactinomas: cabergoline and bromocriptine. Although bromocriptine is deemed a secondary option after cabergoline, its lower cost may be a consideration for some patients. The purpose of this study is to analyze patients treated with different DAs during 12 months period and to identify the unchangeabl...